Ontology highlight
ABSTRACT: Study objectives
To validate the Sustained Attention to Response Task (SART) as a treatment effect measure in narcolepsy, and to compare the SART with the Maintenance of Wakefulness Test (MWT) and the Epworth Sleepiness Scale (ESS).Design
Validation of treatment effect measurements within a randomized controlled trial (RCT).Patients
Ninety-five patients with narcolepsy with or without cataplexy.Interventions
The RCT comprised a double-blind, parallel-group, multicenter trial comparing the effects of 8-w treatments with pitolisant (BF2.649), modafinil, or placebo (NCT01067222). MWT, ESS, and SART were administered at baseline and after an 8-w treatment period. The severity of excessive daytime sleepiness and cataplexy was also assessed using the Clinical Global Impression scale (CGI-C).Measurements and results
The SART, MWT, and ESS all had good reliability, obtained for the SART and MWT using two to three sessions in 1 day. The ability to distinguish responders from nonresponders, classified using the CGI-C score, was high for all measures, with a high performance for the SART (r = 0.61) and the ESS (r = 0.54).Conclusions
The Sustained Attention to Response Task is a valid and easy-to-administer measure to assess treatment effects in narcolepsy, enhanced by combining it with the Epworth Sleepiness Scale.
SUBMITTER: van der Heide A
PROVIDER: S-EPMC4481014 | biostudies-literature | 2015 Jul
REPOSITORIES: biostudies-literature

Sleep 20150701 7
<h4>Study objectives</h4>To validate the Sustained Attention to Response Task (SART) as a treatment effect measure in narcolepsy, and to compare the SART with the Maintenance of Wakefulness Test (MWT) and the Epworth Sleepiness Scale (ESS).<h4>Design</h4>Validation of treatment effect measurements within a randomized controlled trial (RCT).<h4>Patients</h4>Ninety-five patients with narcolepsy with or without cataplexy.<h4>Interventions</h4>The RCT comprised a double-blind, parallel-group, multic ...[more]